Replies to post #117135 on Biotech Values

[DewDiligence]

CEPH acquires ChemGenex (CXS.AX) for A$0.70/sh, a 59% premium:

http://finance.yahoo.com/news/Cephalon-Launches-Recommended-prnews-4076503659.html?x=0

The deal value for the 71% of CXS.AX CEPH did not already own is A$159M (US$163M).